Prognostic value and clinical impact of (18)FDG-PET in the management of children with Burkitt lymphoma after induction chemotherapy

被引：20
作者：
Bailly, Clement [1 ]
Eugene, BaillyThomas [1 ]
Couec, Marie-Laure [2 ]
Strullu, Marion [2 ]
Frampas, Eric [3 ,4 ]
Campion, Loic [4 ,5 ]
Kraeber-Bodere, Francoise [1 ,4 ]
Bodet-Milin, Caroline [1 ,4 ]
机构：
[1] Univ Hosp, Dept Nucl Med, Nantes, France
[2] Univ Hosp, Dept Pediat Oncol, Nantes, France
[3] Univ Hosp, Dept Radiol, Nantes, France
[4] INSERM, CRCNA, CNRS, UMR 6299,U892, Nantes, France
[5] Canc Ctr ICO Rene Gauducheau, Dept Biometr, Nantes, France
来源：
FRONTIERS IN MEDICINE | 2014年 / 1卷
关键词：
Burkitt lymphoma; FDG-PET; pediatric lymphoma; induction chemotherapy; Deauville criteria;
D O I：
10.3389/fmed.2014.00054
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Objective: Burkitt lymphoma (BL) is a rare and aggressive form of B-cell lymphoma that is curable using intensive chemotherapy. Obtaining a complete response (CR) at the end of induction chemotherapy is a major prognostic factor. This study retrospectively evaluates the potential impact of (18)FDG-PET in the management of children with BL after induction chemotherapy, and the prognostic performance of the Deauville criteria. Methods: Nineteen children with BL treated according to the French LMB2001 protocol between 2005 and 2012 were included. (18)FDG-PET and conventional imaging (CI) were performed after induction chemotherapy to confirm CR. (18)FDG-PET was interpreted according to Deauville criteria with follow-up and/or histology as the gold standard. Results: (18)FDG-PET was negative in 15 cases, in agreement with CI in 9/15 cases. The six discordant cases confirmed to be negative by histology, were considered as true negative for (18)FDG-PET. Negative predictive value (NPV) of CI and (18)FDG-PET were 73 and 93%, respectively. The 5-year progression-free survival (PFS) was significantly higher in patients with negative (18)FDG-PET than those with positive (18)FDG-PET (p = 0.011). Conclusion: (18)FDG-PET interpreted using Deauville criteria can help confirm CR at the end of induction chemotherapy, with a prognostic impact on 5-year PFS. Its high NPV could limit the use of residual mass biopsy. Given the small size of our population, these results need to be confirmed by future prospective studies on a larger population.
引用
收藏
页数：7
相关论文
共 30 条
[1]   FDG-PET in 10 children with non-Hodgkin's lymphoma:: Initial experience in staging and follow-up [J].
Amthauer, H ;
Furth, C ;
Denecke, T ;
Hundsdoerfer, P ;
Voelker, T ;
Seeger, K ;
Stöver, B ;
Henze, G .
KLINISCHE PADIATRIE, 2005, 217 (06) :327-333
[2]  
[Anonymous], 2009, HEMATOL AM SOC HEMAT
[3]   Improved outcome in children with advanced stage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children Cancer Study Group (UKCCSG) 9002 protocol [J].
Atra, A ;
Imeson, JD ;
Hobson, R ;
Gerrard, M ;
Hann, IM ;
Eden, OB ;
Carter, RL ;
Pinkerton, CR .
BRITISH JOURNAL OF CANCER, 2000, 82 (08) :1396-1402
[4]   Pediatric Nonlymphoblastic Non-Hodgkin Lymphoma: Baseline, Interim, and Posttreatment PET/CT versus Contrast-enhanced CT for Evaluation-A Prospective Study [J].
Bakhshi, Sameer ;
Radhakrishnan, Venkatraman ;
Sharma, Punit ;
Kumar, Rakesh ;
Thulkar, Sanjay ;
Vishnubhatla, Sreenivas ;
Dhawan, Deepa ;
Malhotra, Arun .
RADIOLOGY, 2012, 262 (03) :956-968
[5]   Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group [J].
Barrington, Sally F. ;
Mikhaeel, N. George ;
Kostakoglu, Lale ;
Meignan, Michel ;
Hutchings, Martin ;
Mueeller, Stefan P. ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Fisher, Richard I. ;
Trotman, Judith ;
Hoekstra, Otto S. ;
Hicks, Rodney J. ;
O'Doherty, Michael J. ;
Hustinx, Roland ;
Biggi, Alberto ;
Cheson, Bruce D. .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3048-+
[6]   Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study [J].
Cairo, Mitchell S. ;
Sposto, Richard ;
Gerrard, Mary ;
Auperin, Anne ;
Goldman, Stanton C. ;
Harrison, Lauren ;
Pinkerton, Ross ;
Raphael, Martine ;
McCarthy, Keith ;
Perkins, Sherrie L. ;
Patte, Catherine .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04) :387-393
[7]   Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma [J].
Carrillo-Cruz, Estrella ;
Marin-Oyaga, Victor A. ;
Sole Rodriguez, Maria ;
Borrego-Dorado, Isabel ;
de la Cruz Vicente, Fatima ;
Quiroga Cantero, Eduardo ;
Manzanares Perez, Marina ;
Capote, Francisco J. ;
Ramirez Sanchez, Maria J. ;
Espigado Tocino, Ildefonso ;
Perez-Vega, Herminia ;
Vazquez-Albertino, Ricardo ;
Perez-Simon, Jose A. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (01) :23-30
[8]   Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas [J].
Cheson, BD ;
Horning, SJ ;
Coiffier, B ;
Shipp, MA ;
Fisher, RI ;
Connors, JM ;
Lister, TA ;
Vose, J ;
Grillo-López, A ;
Hagenbeek, A ;
Cabanillas, F ;
Klippensten, D ;
Hiddemann, W ;
Castellino, R ;
Harris, NL ;
Armitage, JO ;
Carter, W ;
Hoppe, R ;
Canellos, GP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) :1244-1253
[9]   Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification [J].
Cheson, Bruce D. ;
Fisher, Richard I. ;
Barrington, Sally F. ;
Cavalli, Franco ;
Schwartz, Lawrence H. ;
Zucca, Emanuele ;
Lister, T. Andrew .
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (27) :3059-+
[10]   Explorative analyses on the value of interim PET for prediction of response in pediatric and adolescent non-Hodgkin lymphoma patients [J].
Furth, Christian ;
Steffen, Ingo G. ;
Erdrich, Anne S. ;
Hundsdoerfer, Patrick ;
Ruf, Juri ;
Henze, Guenter ;
Schoenberger, Stefan ;
Amthauer, Holger ;
Hautzel, Hubertus .
EJNMMI RESEARCH, 2013, 3 :1-11
123